ストックスクリーナーアプリを入手
3.53
1.44%
0.05
前日終値:
$3.48
開ける：
$3.51
24時間の取引高:
319.10K
Relative Volume:
0.39
時価総額：
$64.64M
収益：
$114.73M
当期純損益:
$-140.94M
株価収益率:
-1.279
EPS:
-2.76
ネットキャッシュフロー:
$-126.18M
1週間 パフォーマンス:
+4.75%
1か月 パフォーマンス:
-27.96%
6か月 パフォーマンス:
-73.56%
1年 パフォーマンス:
-62.70%
1日の値動き範囲:
$3.46
$3.69
1週間の範囲:
$3.35
$3.69
52週間の値動き範囲:
$3.10
$21.98
Outset Medical Inc Stock (OM) Company Profile
Compare OM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.53 | 63.72M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | 開始されました | BTIG Research | Buy |
| 2024-04-05 | アップグレード | CL King | Neutral → Buy |
| 2024-01-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-17 | 開始されました | CL King | Neutral |
| 2022-11-11 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-07-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | 開始されました | Cowen | Outperform |
| 2021-04-19 | 開始されました | Wells Fargo | Overweight |
| 2020-12-16 | 開始されました | Oppenheimer | Perform |
| 2020-10-12 | 開始されました | Barclays | Overweight |
| 2020-10-12 | 開始されました | BofA Securities | Buy |
| 2020-10-12 | 開始されました | Goldman | Buy |
| 2020-10-12 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-12 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-10-12 | 開始されました | Stifel | Buy |
すべてを表示
Outset Medical Inc (OM) 最新ニュース
OM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FDA Clears Outset Medical’s Next-Generation Hemodialysis System - Medical Product Outsourcing
Outset Medical Earnings Call Highlights Margin Turnaround - TipRanks
Outset Medical webinar spotlights Community Health Systems insourced dialysis expansion - Traders Union
Outset Medical, Inc. (OM) Stock Analysis: A Potential 211% Upside Sparks Investor Interest - DirectorsTalk Interviews
Aug Retail: What is Outset Medical Incs 5 year growth outlookPortfolio Return Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Exit Recap: Can Outset Medical Inc sustain earnings growthForecast Cut & High Yield Stock Recommendations - baoquankhu1.vn
OMOutset Medical, Inc. Latest Stock News & Market Updates - Stock Titan
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Yahoo Finance
Outset Medical Q4 Results Show Strong Analyst Support - Intellectia AI
Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel Brottem sells $9,520 in stock - Investing.com
Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com UK
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan
Outset Medical, Inc. (NASDAQ:OM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
OM (NASDAQ: OM) Form 144: Proposed sale of 9,319 RSU‑settled shares - Stock Titan
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion - MSN
Outset Medical, Inc. (NASDAQ:OM) Q4 2025 Earnings Call Transcript - Insider Monkey
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results - Yahoo Finance
RBC Capital Reaffirms Their Hold Rating on Outset Medical (OM) - The Globe and Mail
Outset Medical (NASDAQ:OM) Given New $15.00 Price Target at BTIG Research - MarketBeat
Outset Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Outset Medical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com Canada
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc. (OM) Misses Q4 EPS by 60c - StreetInsider
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Outset Medical Q4 Earnings Report: What Investors Need to Know - Benzinga
Outset Medical Q4 2025 Earnings Call Transcript - MarketBeat
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical Inc (OM) Q4 2025: Everything You Need To Know Ahe - GuruFocus
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating - Finviz
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Outset Medical Secures Key FDA Clearance for Next-Generation Dialysis System - AD HOC NEWS
Outset Medical (NASDAQ:OM) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Outset Medical (OM) to Release Quarterly Earnings on Wednesday - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Held Back By Insufficient Growth Even After Shares Climb 35% - simplywall.st
Is Outset Medical Inc benefiting from innovation trendsJuly 2025 Retail & Expert Approved Momentum Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Rating Increased to Hold at Wall Street Zen - MarketBeat
Outset Medical Inc (OM) 財務データ
収益
当期純利益
現金流量
EPS
2.27%
1.94%
大文字化:
|
ボリューム (24 時間):